Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Explore the unique financial literacy challenges women face and how to overcome them. Empower your financial journey with vital insights.
28,655 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Macy’s posts a stronger-than-expected Q4, lifting shares in a downbeat retail environment. The company leans into cre...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Aave asks a New York court to lift a restraining order on ETH set aside for victims of a DeFi breach, arguing the ass...
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
A real estate reform push proposes agent ownership of the national MLS and portal, aiming to reshape loan access, pri...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...
MoonPay seals its fourth acquisition of the year, bringing Decent into the fold as it launches MoonPay Trade to strea...
As the last Baby Boomers retire, their influence lingers in wages, homes, and boardrooms. This report explains how th...
Strategy disclosed a record unrealized loss on its Bitcoin holdings, topping $10 billion as bitcoin trades near $61,0...
James Harris’s lean, quality-first model propelled Harris & Partners to No. 2 among large teams in the 2026 RealTrend...
India restricts Telegram access ahead of the NEET-UG re-exam, hitting hundreds of millions of users and sending Gram ...